Related Experiment Video
Updated: Aug 12, 2026
06:49
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination
Published on: July 29, 2015
Component-specific effects of physostigmine on the cat visual evoked potential
K Arakawa1, N S Peachey, G Celesia
1Department of Neurology, Stricth School of Medicine, Loyola University Chicago, Maywood, IL 60153.
Experimental Brain Research
|January 1, 1993
Summary
Physostigmine alters visual evoked potentials (VEPs) in cats by affecting acetylcholine breakdown. This study reveals distinct positive and negative waveform components contributing to the overall VEP signal.
Area of Science:
- Neuroscience
- Neurophysiology
- Pharmacology
Background:
- Visual evoked potentials (VEPs) reflect visual cortex activity.
- Acetylcholine plays a role in cortical processing.
- Physostigmine inhibits acetylcholinesterase, increasing acetylcholine levels.
Purpose of the Study:
- To investigate the effect of physostigmine on cat primary visual cortex VEPs.
- To elucidate the cholinergic contribution to VEP waveform components.
Main Methods:
- Recording pattern VEPs from the cat pial surface.
- Administering physostigmine intravenously.
- Utilizing scopolamine as a muscarinic antagonist.
- Employing waveform subtraction techniques.
Main Results:
- Physostigmine diminished the P1-N1 amplitude and increased the N1-P2 amplitude.
- These physostigmine-induced changes were long-lasting.
- Scopolamine blocked the effects of physostigmine, indicating muscarinic pathway involvement.
- Waveform subtraction identified distinct positive and negative physostigmine-sensitive and insensitive components.
Conclusions:
- Cholinergic pathways, specifically muscarinic, significantly modulate VEP components.
- The conventional VEP is an algebraic sum of components with different polarities.
- Physostigmine reveals underlying VEP waveform dynamics in the visual cortex.
